1-3 of 3
Jason Li
Close
Sort by
Journal Articles

Lintuzumab-Ac225, a CD33-Directed Antibody Radiotherapy, Targets AML in a Mutation Agnostic Manner

Amanda Chin, Rubin Jiao, Kevin J.H. Allen, Jason Li, Mary Chen, Madhuri Vusirikala, Le-Cun Xu, Patrik Brodin, Monideepa Roy, Mackenzie Malo, William Van der Touw, Ekaterina Dadachova, Denis Beckford-Vera, Helen Kotanides
Journal: Blood
Blood (2023) 142 (Supplement 1): 5750.
https://doi.org/10.1182/blood-2023-187498
Published: 2023
Journal Articles

Effects of Renal Function on the Pharmacokinetics of Panobinostat in Patients with Advanced Cancer: A Phase I Study

Sunil Sharma, MD, Emile Voest, MD, PhD, Nicole Hagner, MD, P.O. Witteveen, MD, PhD, Martijn Lolkema, MD, PhD, Neeraj Agarwal, MD, Sue-zette Valera, Jason Li, PhD, Derek Mires, Maria Grazia Porro, PhD, Margaret M. Woo, PharmD, Dagmar Hess, MD
Journal: Blood
Blood (2011) 118 (21): 5001.
https://doi.org/10.1182/blood.V118.21.5001.5001
Published: 2011
Journal Articles

Effects of Hepatic Function on the Pharmacokinetics and Safety of Panobinostat in Patients with Advanced Cancer: A Phase I Study

Dagmar Hess, MD, Nicole Hagner, MD, Sally Clive, MD, Hans Gelderblom, MD, PhD, Eva Rossmann, MD, PhD, Neeraj Agarwal, MD, Maria Grazia Porro, PhD, Thomas Hengelage, PhD, Annie St-Pierre, PhD, Lucien Gazi, PhD, Jason Li, PhD, Margaret M. Woo, PharmD, Sunil Sharma, MD
Journal: Blood
Blood (2011) 118 (21): 5007.
https://doi.org/10.1182/blood.V118.21.5007.5007
Published: 2011